medigraphic.com
ISSN 0210-5187 (Electronic)

2007, Number 4

<< Back Next >>

Med Cutan Iber Lat Am 2007; 35 (4)

Steven-Johnson syndrome after radiotherapy and probably related to amifostine

Ríos KY, Muñoz GJL, González FJA, Rodríguez NI, Fernández DDA, Cháves ÁA

Language: Spanish
References: 9
Page: 200-202
PDF size: 164.55 Kb.


ABSTRACT

The Stevens-Johnson syndrome is an acute inflammatory disease, caused by hipersensitivity of the skin and mucous membrane. It can be induced by many precipitant factors, including pharmacological agents and infections. The incidence rate of severe secondary cutaneous reactions is less than 1%, the Stevens-Johnson syndrome being one of them. We report a case of Stevens-Johnson syndrome probably related to subcutaneous amifostine administration during radiotherapy procedure.


REFERENCES

  1. 1.Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, et al. Phase III randomized trial of amifostine as a radiprotection in head and neck cancer. J Clin Oncol 2000;18:3339-45.

  2. 2.Atahan IL, Özyar E, Sahin S, Ildis B, Karaduman A. Two cases of Stevens-Johnson síndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy. Br Dermatol 2000;143:1072-3.

  3. 3.Astudillo L, Maachi B, Benyoucef A, Game X, Rives M, Bachaud JM. Stevens-Johnson syndrome after amifostine during radiotherapy. Int J Dermatol 2004;43:284-5.

  4. 4.Samper PM, Rodríguez A, Pastor L, Sáez J, Vallejo C, López C. Síndrome de Stevens-Johnson probablemente asociado a tratamiento con amifostina durante la radioterapia. Rev Oncol 2004;6:538-40.

  5. Demiral AN, Yerebakan O, Sinsin V, Alpsoy E. Amifostine-iduced toxic epidermal necrolys during radiotherapy: a case report. Jpn J Clin Oncol 2002;32:477-79.

  6. 6.Crosi A, Borges S, Estévez F. Reacciones adversas medicamentosas graves: síndrome de Stevens-Johnson y necrólisis epidérmicatóxica. Rev Med Uruguay 2004;20:172-7.

  7. 7.Boccia R, Anné PR, Bourhis J, et al. Assessment and manegement of cutaneous reactions with amifostine administration: finding of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Rad Oncol Biol Phys 2004;60:302-309.

  8. Redondo P, Vicente J, España A, et al. Photoinduced toxic epidermal necrolysis caused by clobazam. Br J Dermatol 1996;135:999-1002.

  9. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1972-85.




2020     |     www.medigraphic.com